• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血液透析中补体和白细胞介导的肺功能障碍

Complement and leukocyte-mediated pulmonary dysfunction in hemodialysis.

作者信息

Craddock P R, Fehr J, Brigham K L, Kronenberg R S, Jacob H S

出版信息

N Engl J Med. 1977 Apr 7;296(14):769-74. doi: 10.1056/NEJM197704072961401.

DOI:10.1056/NEJM197704072961401
PMID:840277
Abstract

During hemodialysis, cardiopulmonary decompensation may appear in uremic patients, possibly caused by plugging of pulmonary vessels by leukocytes. In 34 patients we noted leukopenia (20% of initial levels) during hemodialysis that in 15 was associated with impaired pulmonary function. When we infused autologous plasma, incubated with dialyzer cellophane, into rabbits and sheep, sudden leukopenia and hypoxia occurred, with doubling of pulmonary-artery pressures and quintupling of pulmonary-lymph effluent. Histologic examination showed severe pulmonary-vessel-leukostasis and interstitial edema. The syndrome was prevented by preinactivation of complement but was reproduced by infusions of plasma in which complement was activated by zymosan. Thus, acute pulmonary dysfunction from complement-mediated leukostasis may play a major part in the acute cardiopulmonary complications of cellophane-membrane hemodialysis.

摘要

在血液透析过程中,尿毒症患者可能会出现心肺失代偿,这可能是由白细胞堵塞肺血管所致。我们观察到34例患者在血液透析期间出现白细胞减少(降至初始水平的20%),其中15例伴有肺功能受损。当我们将与透析器玻璃纸孵育过的自体血浆注入兔和羊体内时,突然出现白细胞减少和缺氧,肺动脉压加倍,肺淋巴流出量增至五倍。组织学检查显示严重的肺血管白细胞淤滞和间质水肿。该综合征可通过预先灭活补体来预防,但通过注入经酵母聚糖激活补体的血浆可再次引发。因此,补体介导的白细胞淤滞引起的急性肺功能障碍可能在玻璃纸膜血液透析的急性心肺并发症中起主要作用。

相似文献

1
Complement and leukocyte-mediated pulmonary dysfunction in hemodialysis.血液透析中补体和白细胞介导的肺功能障碍
N Engl J Med. 1977 Apr 7;296(14):769-74. doi: 10.1056/NEJM197704072961401.
2
Hemodialysis leukopenia. Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes.血液透析性白细胞减少。透析器玻璃纸膜激活补体导致肺血管白细胞淤滞。
J Clin Invest. 1977 May;59(5):879-88. doi: 10.1172/JCI108710.
3
Pulmonary leukostasis and its relationship to pulmonary dysfunction in sheep and rabbits.绵羊和兔子的肺白细胞淤滞及其与肺功能障碍的关系。
Circ Res. 1980 Feb;46(2):175-80. doi: 10.1161/01.res.46.2.175.
4
Dialysis, neutropenia, lung dysfunction and complement.
N Engl J Med. 1977 Apr 7;296(14):810-2. doi: 10.1056/NEJM197704072961410.
5
Hemodialysis-associated neutropenia and hypoxemia: the effect of dialyzer membrane materials.
Nephron. 1982;32(1):32-9. doi: 10.1159/000182728.
6
Production of acute pulmonary injury by leukocytes and activated complement.白细胞和活化补体导致急性肺损伤
Surgery. 1980 Jul;88(1):48-58.
7
Effect of dialyzer reuse on complement activation and neutropenia in hemodialysis.透析器复用对血液透析中补体激活和中性粒细胞减少的影响。
J Lab Clin Med. 1984 Sep;104(3):304-11.
8
Modified neutropenic response to re-used dialyzers in patients with chronic renal failure.
Clin Nephrol. 1977 Oct;8(4):422-8.
9
Leukopenia and hypoxemia. Unrelated effects of hemodialysis.
Arch Intern Med. 1979 Oct;139(10):1103-6.
10
Reversal of hemodialysis granulocytopenia and pulmonary leukostasis: A clinical manifestation of selective down-regulation of granulocyte responses to C5adesarg.血液透析所致粒细胞减少症及肺部白细胞淤滞的逆转:粒细胞对C5adesarg反应选择性下调的一种临床表现
J Clin Invest. 1981 May;67(5):1383-91. doi: 10.1172/jci110166.

引用本文的文献

1
Biocompatibility in hemodialysis: artificial membrane and human blood interactions.血液透析中的生物相容性:人工膜与人体血液的相互作用
BMC Nephrol. 2025 Aug 22;26(1):482. doi: 10.1186/s12882-025-04401-y.
2
Increased Cardiovascular Mortality in Hemodialysis: The Role of Chronic Inflammation, Complement Activation, and Non-Biocompatibility.血液透析中心血管死亡率增加:慢性炎症、补体激活和非生物相容性的作用。
Toxins (Basel). 2025 Jul 10;17(7):345. doi: 10.3390/toxins17070345.
3
The Janus-faced nature of complement in hemodialysis: interplay between complement, inflammation, and bioincompatibility unveiling a self-amplifying loop contributing to organ damage.
血液透析中补体的双面性:补体、炎症和生物不相容性之间的相互作用揭示了一个自我放大的循环,导致器官损伤。
Front Nephrol. 2024 Dec 3;4:1455321. doi: 10.3389/fneph.2024.1455321. eCollection 2024.
4
Hemoincompatibility in Hemodialysis-Related Therapies and Their Health Economic Perspectives.血液透析相关治疗中的血液不相容性及其健康经济学视角。
J Clin Med. 2024 Oct 16;13(20):6165. doi: 10.3390/jcm13206165.
5
Immunophenotypic Characterization of Citrate-Containing A Concentrates in Maintenance Hemodialysis: A Pre-Post Study.维持性血液透析中含柠檬酸盐浓缩物的免疫表型特征:一项前后对照研究。
Int J Nephrol. 2023 Sep 27;2023:7772677. doi: 10.1155/2023/7772677. eCollection 2023.
6
Complement and COVID-19: Three years on, what we know, what we don't know, and what we ought to know.补体与 COVID-19:三年过去了,我们知道了什么,不知道什么,以及我们应该知道什么。
Immunobiology. 2023 May;228(3):152393. doi: 10.1016/j.imbio.2023.152393. Epub 2023 May 11.
7
Immune System Dysfunction and Inflammation in Hemodialysis Patients: Two Sides of the Same Coin.血液透析患者的免疫系统功能障碍与炎症:同一硬币的两面
J Clin Med. 2022 Jun 28;11(13):3759. doi: 10.3390/jcm11133759.
8
Plasma C4 level was associated with mortality, cardiovascular and cerebrovascular complications in hemodialysis patients.血浆 C4 水平与血液透析患者的死亡率、心血管和脑血管并发症相关。
BMC Nephrol. 2022 Jun 29;23(1):232. doi: 10.1186/s12882-022-02829-0.
9
Patients with hemodialysis-induced hypoxemia had a poor prognosis of COVID-19.血液透析引起的低氧血症患者的新冠病毒疾病预后较差。
Ren Replace Ther. 2022;8(1):22. doi: 10.1186/s41100-022-00408-5. Epub 2022 May 20.
10
Biocompatibility of Surface-Modified Membranes for Chronic Hemodialysis Therapy.用于慢性血液透析治疗的表面改性膜的生物相容性
Biomedicines. 2022 Apr 3;10(4):844. doi: 10.3390/biomedicines10040844.